Lara Tolbert

Lara Tolbert has a strong background in medical writing, with their most recent role being Director of Medical Writing at Lyell Immunopharma since March 2022. Prior to that, they worked as a Principal Medical Writer at Juno Therapeutics from March 2015 to February 2022. Lara also has experience as a Contract Medical Writer at LMT Medical Writing from April 2014 to March 2015 and as a Senior Medical Writer at ZymoGenetics from October 2007 to March 2014. Lara began their career as a Medical Writer at Scios Inc from August 2004 to December 2005 and later worked as a Contract Medical Writer at the same company from October 2006 to October 2007. Before entering the field of medical writing, they worked as a Scientist at Cato Research from January 2002 to July 2004. Lara also has experience as a Postdoctoral Associate at Yale University School of Medicine from June 1998 to August 2001.

Lara Tolbert holds a Ph.D. in Pharmaceutical Chemistry from the University of California, San Francisco - School of Medicine. Prior to that, they earned a B.S. in Chemistry from the Georgia Institute of Technology. In addition, Lara has obtained a certification from the Board of Editors in the Life Sciences (BELS). The specific month and year of their certification acquisition is not provided.